³Ô¹ÏÍøÕ¾

Latest clinical trial News | Page 2

From thoughts to words: How AI deciphers neural signals to help a man with ALS speak
Amplia says five patients recording sustained reduction in tumour size in trial
Counselling May Prevent Heart Attacks
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
Chimeric says Phase 1/2 CHM CDH17 CAR-T GMP manufacturing complete
Infectious diseases spike when kids return to school − here’s what you can do about it
New investigational treatment may prevent severe disease in fetuses and newborns
Researchers develop ground-breaking immunotherapy for aggressive brain cancer
CSIRO under attack, staff demand Ministerial intervention
New Hope For Heart Attack Patients
Preclinical study explores approved drug for ovarian cancer
Adoption of International Scientific Guidelines in Australia
Could a common anti-inflammatory and a painkiller fight heart disease?
Australian researchers develop a donor stem cell therapy for the successful treatment of osteoarthritis
Commonly used drug may extend women’s fertility, claim researchers – here’s what you need to know about rapamycin
Successful first-in-human implantation of the BiVACOR Total Artificial Heart by Baylor and THI doctors
Model Offers Insights Into Parkinson’s Disease Process
The Texas Heart Institute Implants BiVACOR® Total Artificial Heart
Chimeric Therapeutics says first patient enrolled in cell therapy trial
Research into psychedelic medicines to treat anxiety wins ANS Illumina Neurogenomics Award 2024
Could Natural Medicine Solve Recurrent Dizziness?
Alterity Therapeutics reports positive interim data from Multiple System Atrophy trial
Views sought in ³Ô¹ÏÍøÕ¾ Health and Medical Research Workforce Audit
Toxoplasma is a common parasite that causes birth defects – but the US doesn’t screen for it during pregnancy
Korotkoff sounds: the reason why your blood pressure reading may be inaccurate
Five HKUST Research Projects Receive Funding from First Batch of RAISe+ Scheme
Amplia anounces completion of recruitment of first 26 patients in Phase 2 trial
Dimerix says the recruitment of adolescent patients to commence in Phase 3 trial
New trial therapy appears to rapidly reverse life-changing sepsis-induced brain injury
Actinogen’s phase 2a depression trial completes final patient visit
Alzheimer’s risk higher if your mother had cognitive problems
Unchartered waters: Swinburne explores how virtual sailing could treat major depressive disorder (MDD) in world first trial
Members Sought For New Policy Taskforce
Service dogs can reduce the severity of PTSD for veterans – new research
Imugene doses the first patient in pioneering Phase 1 onCARlytics tria
Ketamine slow-release tablet reduces symptoms of severe depression: clinical trial
Popular Diabetes Drugs May Reduce Risk Of Dementia
Groundbreaking technology is first to allow patients to add daily symptoms to their health record
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit public health
Ground-breaking clinical trial to test the effectiveness of Germicidal Ultraviolet Light to fight airborne viruses
Government backs WA clinicians to continue vital medical research
New lung biopsy procedure revolutionises cancer diagnosis process
Fifth patient is treated with the OncoSil device in PANCOSIL trial
New study: Educational intervention reduces opioid doses and mortality
Can Alzheimer’s really be reversed, as a new documentary claims?
Immutep announces major capital raise and third collaboration with MSD
JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
Neuren says trial shows significant improvements in Pitt Hopkins syndrome